What it’s essential know:

– Alchemy, a healthcare firm targeted on enhancing entry to drugs for underserved populations, raises $31 million in seed funding.

– The funding was led by Andreessen Horowitz (a16z) Bio + Well being, with participation from Earvin “Magic” Johnson, Sandberg Bernthal Enterprise Companions, Banc of California and different buyers.

Increasing entry to take care of HIV communities

Alchemy supplies the infrastructure and expertise essential to determine and function in-house pharmacy applications, with an emphasis on serving clinics with massive HIV and Hepatitis C (HCV) affected person populations. These communities typically face vital boundaries to accessing important medicines and healthcare providers.

A complete strategy to pharmacy providers

Alchemy's platform supplies a complete strategy to supporting inner pharmacy applications:

• Bodily infrastructure: Offers the mandatory gear and sources to arrange and function your personal pharmacy.
• Scientific applications: Designs and implements scientific pharmacy applications to optimize treatment administration and affected person care.
• Technological options: Deploy expertise merchandise to streamline pharmacy operations, enhance affected person communication and enhance treatment compliance.

Collaboration with Security Web Clinics

Alchemy is initially working with Federally Certified Well being Facilities (FQHCs), STD clinics and Ryan White clinics to implement its platform. These security internet clinics play a essential position in offering well being care to underserved communities.

Confirmed expertise and affect

Alchemy's founding group brings intensive expertise in scientific care, pharmacy operations, expertise and international well being initiatives. They’ve a confirmed observe file of constructing and scaling pharmacy applications, together with the most important HIV entry program in Africa and pharmacies which have stuffed greater than 25 million prescriptions within the US.

Accelerating development and increasing providers

This new funding will allow Alchemy to:

• Speed up development: Increase attain and launch in-house pharmacy applications in 20 states over the following 12 months.
• Develop a cell clinic program: Increase its providers to cell clinics, additional growing entry to take care of underserved communities.
• Enhance the digital platform: Strengthen the digital platform to streamline pharmacy operations and enhance affected person communication.

Enhancing well being outcomes and monetary affect

By working with Alchemy, clinics can:

• Increase affected person attain: Increase entry to important medicines and pharmacy providers for his or her sufferers.
• Enhance well being outcomes: Enhance treatment adherence and enhance affected person well being outcomes by means of scientific pharmacy applications.
• Optimize the monetary affect: Enhance the monetary sustainability of their pharmacy applications by means of environment friendly operations and expertise options.

“After greater than a decade working in Africa to construct the most important HIV entry program on the earth, I used to be shocked to be taught that HIV treatment adherence in Africa is best than right here in the US. I consider the most important barrier to accessing drugs for HIV sufferers is the friction that exists in navigating the U.S. pharmacy system,” stated Peter Park, Founder and Co-CEO of Alchemy. “By bringing the clinic and pharmacy into one location, we’re offering distinctive options that meet the wants of HIV and HCV populations throughout the nation.”